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Abstract 
Background and objectives: The aim of this paper is to report a case in which the damage control 
resuscitation (DCR) approach was successfully used to promote hemostatic resuscitation in a 
polytraumatized patient with severe hemorrhagic shock.
Case report: Female patient, 32 years of age, with severe hemorrhagic shock due to polytrauma 
with hip fracture, who developed acidosis, coagulopathy, and hypothermia. During ﬂ uid 
resuscitation, the patient received blood products transfusion of fresh frozen plasma/packed red 
blood cells/platelet concentrate at a ratio of 1:1:1 and evolved intraoperatively with improvement 
in perfusion parameters without requiring vasoactive drugs. At the end of the operation, the 
patient was taken to the intensive care unit and discharged on the seventh postoperative day.
Conclusion: The ideal management of traumatic hemorrhagic shock is not yet established, but 
the rapid control of bleeding and perfusion recovery and well-deﬁ ned therapeutic protocols are 
fundamental to prevent progression of coagulopathy and refractory shock.
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
Hemostatic Resuscitation in Traumatic 
Hemorrhagic Shock: Case Report
José Osvaldo Barbosa Neto* 1, Marcos Fernando Breda de Moraes 2, 
Ricardo Souza Nani 3, Joel Avancini Rocha Filho 4, Maria José Carvalho Carmona  5
1. Anesthesiologist at Department of Anesthesia, Hospital das Clínicas da 
Faculdade de Medicina da Universidade de São Paulo (FMUSP).
2. Resident Physician at Department of Anesthesia, Hospital das Clínicas, FMUSP; Specialization in Anesthesiology, 
Centro de Ensino e Treinamento, Sociedade Brasileira de Anestesiologia (SBA).
3. TSA; Anestheiologist, at Department of Anesthesia, Hospital das Clínicas, FMUSP
4. TSA; Anestheiologist, at Department of Anesthesia, Hospital das Clínicas, FMUSP; PHD in Medical Sciences, FMUSP 
5. TSA; Associate Professor, FMUSP
Received from Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil.
Submitted on June 29, 2011. Approved on March 5, 2012.
Keywords:
Blood Component; 
Multiple trauma; 
Shock, 
Hemorrhagic.
CLINICAL INFORMATION
ISSN  © 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
* Corresponding author: Avenida Angélica, 1071/101  Santa Cecília 
01227-100 – São Paulo, SP, Brazil.  
E-mail: osvbarbosa@yahoo.com.br
Introduction
Uncontrolled hemorrhage accounts for 30-40% of early mor-
tality in trauma and more than 80% mortality in the operating 
room, reported as the leading cause of potentially prevent-
able death 1. These patients often progress to varying degrees 
of coagulopathy, hypothermia, and metabolic acidosis, con-
sidered the lethal triad of trauma and major predictive of 
morbidity and mortality in polytraumatized patients.
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obtaining large-bore venous access (venoclysis with a 14G 
catheter), ﬂ uid resuscitation and invasive vascular monitor-
ing with mean arterial pressure (MAP) and central venous 
pressure (CVP) was initiated.
Initial phase of resuscitation was made with the rapid 
infusion system of warm ﬂ uids (Level 1 infuser®) for transfu-
sion and adjusted to maintain MAP > 70 mm Hg, obtained with 
adrenergic pharmacological support (noradrenaline).
After the ﬁ fth PRBC transfusion, the ﬂ uid transfusion 
protocol was triggered and the transfusion strategy fol-
lowed the FFP/PRBC/PC ratio of 1:1:1, along with Ringer’s 
Lactate infusion of 15 mL.kg-1.h-1 and correction of metabolic 
disorders. Table 2 presents data regarding the transfusion of 
blood products.
At the end stage of initial resuscitation, the patient had 
received PRBC (10U), FFB (9U), and PC (10U); the pelvic frac-
ture had been surgically ﬁ xed, with surgical bleeding under 
control; there was evolution with improved perfusion rates, 
progressive reduction of the pharmacological hemodynamic 
support, and temperature recovery.
Laboratory tests conﬁ rmed the clinical improvement 
and successful recovery of perfusion, hemodynamics, and 
hemostasis. The massive transfusion protocol and infusion of 
norepinephrine were then discontinued (Table 3).
Surgical time was approximately 120 minutes; 30 minutes 
after the procedure the patient developed a skin rash and 
mild angioedema, which resolved spontaneously 2 hours 
later. Figure 1 shows the evolution of coagulopathy during 
patient’s care.
The patient was taken to the ICU where she received 
packed red blood cells, without requiring other blood 
products. Postoperatively, she was hemodynamically stable 
without requiring norepinephrine and was kept under seda-
tion and serial neurological evaluation due to the blood pres-
ence in the right ventricle, which evolved without surgical 
indication.
On the third postoperative day, sedation was suspended, 
resulting in extubation on the seventh day after surgery and 
discharged from the ICU to a secondary support unit on the 
eighth day. The patient was discharged from the hospital on 
the 63rd postoperative day.
Table 1  Initial Data Monitoring in the Operating Room.
Mean blood pressure 40 mm Hg
Heart rate 144 ppm
Temperature 34.6ºC
Central venous pressure 3 mm Hg
ETCO2* 25 mm Hg
*ETCO2: end tidal CO2.
Table 2  Blood Products transfused within 24 hours.
EU 1st hour 2nd hour 3rd hour Admission 
(ICU)**
12 hours 24 hours
PRBCs 2 3 3 2 1 0 0
FFP 0 4 3 2 0 0 0
CP 0 0 10 0 0 0 0
EU: emergency unit; ICU: intensive care unit; PRBCs: packed red blood cells, FFP: fresh frozen plasma, CP: platelet 
concentrate.
Fluid resuscitation in traumatic hemorrhagic shock is 
still a matter of debate. The classical approach (infusion 
of large volumes of ﬂ uid), type of ﬂ uid, and the goals to 
be achieved have been controversial, as there is evidence 
that conventional strategies may exacerbate coagulopathy, 
bleeding, and mortality 2,3.
The concept of hemostatic resuscitation was developed 
from the experience of emergency medicine in the military, 
especially during wars in Vietnam, Iraq, and Afghanistan. 
Hemostatic resuscitation involves early administration of 
blood products in order to restore both perfusion and coagu-
lation and minimize the use of large volumes of crystalloid 
and their dilutive effect on coagulation 4,5.
In this context, resuscitation is the early use of whole 
blood or packed red blood cells (PRBC), fresh frozen plasma 
(FFP), and platelet concentrate (PC) high administration with 
ﬁ xed ratio between products 5-7.
The objective of this case report is to discuss a case in 
which the hemostatic resuscitation has been used success-
fully in a patient victim of polytrauma with severe hemor-
rhagic shock.
Case report
Female patient, aged 32 years, with polytrauma result-
ing from car crash against truck, who was brought to the 
emergency department of the Hospital das Clínicas of 
the Faculdade de Medicina da Universidade de São Paulo 
by the Emergency Care Rescue Time (Grupo de Resgate e 
Atendimento a Urgências – GRAU), air medical service, in 
the city of São Paulo.
Upon admission, the patient was unconscious, using a 
cervical immobilization collar, intubated, and on ventilatory 
support. During clinical examination, she presented with 
tachycardia; hypotension; anisocoria; Glasgow coma scale 3; 
and pelvic, humerus, and left jaw fractures; in addition to 
active bleeding in the right frontoparietal region and large 
hematoma in the pelvic and hypogastric region.
Additional tests, such as ultrasound, showed no free 
ﬂ uid in the abdominal cavity, chest X-ray without changes, 
and brain computed tomography with evidence of bleeding 
into the right ventricle, but without signs of intracranial 
hypertension.
The initial ﬂ uid resuscitation was performed with two lit-
ers of Ringer’s Lactate and three PRBCs. After closed external 
immobilization of the pelvis, the patient was immediately 
taken to the operating room (OR) for hip fracture surgical 
treatment. The time interval between the patient’s arrival to 
hospital and OR admission was approximately 60 minutes.
In the OR, blood pressure was not identiﬁ ed at the ini-
tial noninvasive hemodynamic monitoring, and the patient 
had only palpable carotid pulse (140 ppm) (Table 1). After 
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Discussion
This case report shows that an early, aggressive approach for 
hemorrhagic shock management, using the damage control 
resuscitation (DCR) strategy that focuses on hypotensive 
resuscitation and hemostatic transfusion to control surgical 
bleeding, plays an important role towards a successful treat-
ment. Current approaches prioritize the rapid identiﬁ cation 
and correction of circulatory collapse, the major event 
responsible for mortality in these patients.
Although the administration of crystalloids is an estab-
lished practice in cases of class I-II hemorrhage, the ﬂ uid 
resuscitation strategy in trauma with hemorrhagic shock 
(class III-IV) is up for debate 8,9. In this scenario, the DCR 
strategy has received greater attention.
In traumatic hemorrhagic shock, the DCR strategy is one 
of the major therapeutic advances and its application is based 
on three pillars: abbreviated surgery, reversal of coagulopathy 
(hemostatic resuscitation), and hypoperfusion (permissive hy-
potension). This therapy is indicated in class III-IV hemorrhage 
and hemorrhagic shock and its goal is focused on ﬁ ghting the 
lethal triad to abort the vicious cycle of bleeding and avoid 
the picture irreversibility.
The identiﬁ cation of viable candidates to therapy is the 
critical point of DCR. The triggers accepted for instituting the 
hemostatic resuscitation therapy include coagulopathy; blood 
transfusion > 10 U or > 4 U.h-1; metabolic acidosis with base 
deﬁ cit > 5; temperature < 35ºC; and hemodynamic instability 
with insufﬁ cient response to resuscitation 3,10-13.
Reversing coagulopathy is the main goal for treating 
severe bleeding. The predominant mechanism of acute 
trauma coagulopathy (ATC) depends on the degree of mi-
croperfusion dysfunction, nature and severity of trauma, 
and deleterious effects of subsequent medical therapies. 
ATC has complex and multifactorial pathophysiology, which 
compromises hemostasis in its entire cascade. In addition, 
tissue hypoperfusion, metabolic acidosis, hypothermia, and 
hemodilution are other factors that trigger and maintain 
this disorder 14,15.
The metabolic markers of hypoperfusion in acute trauma 
have strong correlation with the incidence of ATC. In 20% of 
cases, frequently admitted patients with base deﬁ cit over 
six showed an incidence of coagulopathy, whereas patients 
without base deﬁ cit showed no change in laboratory markers 
of coagulation 14,16.
On the other hand, in a rapid attempt to restore tissue 
perfusion and oxygen delivery, polytrauma patients usually 
receive crystalloids and packed red cells that have no clotting 
factors, which causes strong dilutional effect on coagulation 
factors. Moreover, the clinical condition of these patients 
is worsened with the usual ﬁ nding of metabolic acidosis 
(pH < 7.1) and hypothermia (temperature < 34°C) – factors 
that solely affect hemostasis.
The causes of hypothermia are multifactorial and inter-
dependent, including changed central thermoregulation; 
reduced endogenous heat production, due to tissue hypop-
erfusion in hemorrhagic shock; exposure to low temperatures 
in the operating room; and infusion of crystalloid solution 
and blood products inadequately warmed 17.
Because the hemostasis process consists of an enzyme 
cascade dependent on a body temperature of about 37°C to 
occur normally, in case of hypothermia there is impairment of 
thrombin generation, platelet aggregation, and ﬁ brin throm-
bi, which occurs simultaneously with hyperﬁ brinolysis 17-20.
Conﬁ rming the deleterious effects of hypothermia on 
coagulation, acidosis appears as a complicating factor, as 
it substantially reduces the rate of thrombus formation, 
assessed by thromboelastography, and platelet aggrega-
tion 5. The high level of lactate (lactate > 90 mg.dL-1) alone 
is proven to contribute to impaired hemostasis via in vitro 
thromboelastography 21.
Table 3  First 24 Hours Laboratory Evolution.
1st hour 2nd hour 3rd hour Admission (ICU)** 12 hours 24 hours
INR 2 1.6 1.2 1.1
APTT-R 2.5 1.3 1.1 1
Temperature (ºC) 34.6 34.8 34.7 35 35.8 35.8
pH 6.8 7.2 7.2 7.2 7.3 7.4
Base excess (mEq.L-1) -12 -3.1 -5.1 -7.3 -4.3 -1.8
Lactate (mg.dL-1) 58 39 35
Hemoglobin (g.dL-1) 3.3 3.7 9.9 6.7 8.6 9.3
Hematocrit (%) 10.1 11.6 28.7 18.2 25.8 27.9
INR: institutional normalized ratio; R-APTT: ratio of activated partial thromboplastin time.
Figure 1  Behavior of INR and R-APTT over 24 Hours.
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The acidosis effect on coagulation is not reversed by 
simple pharmacological correction of acidosis with bicarbo-
nate. Several investigators agree that pH must be over 7.2 
before implementing circumstantial therapies for coagula-
tion disorders, which reinforces the mandatory recovery of 
perfusion in coagulopathy treatment 19,20.
In the case reported, the patient was admitted with se-
vere anemia (Hb = 3.3 g.dL-1), acidosis (pH = 6.8-1), hyperlac-
tatemia (lactate = 58 mg.dL-1), and moderate hypothermia. 
Given the gravity of the case, transfusion was initiated during 
surgery to maintain a ratio of 1:1:1 between blood products, 
with the intention of correcting anemia without increasing 
hemostatic disorder.
In a cohort study, Sperry et al. 6 found that when mas-
sive transfusion is performed, maintaining a high ratio of 
fresh frozen plasma and packed red blood cells, there is an 
overall reduction in transfusion requirements in the ﬁ rst 24 
hours, despite the greater amount of plasma transfused. In 
our case, in the ﬁ rst 12 hours the patient received 11 units 
of PRBCs, 9 units of fresh frozen plasma, and 10 units of 
platelet concentrate.
There were some limitations in this case, such as the 
time to perform laboratory tests and the lack of platelet 
count. Thus, therapy during intraoperative period was given 
empirically based on surgical bleeding, clot formation in the 
ﬁ eld, and presence of microvascular bleeding.
Although the optimal therapeutic approach to trau-
matic hemorrhagic shock is not yet fully established, 
the rapid control of bleeding and recovery of perfusion, 
in addition to well-deﬁ ned therapeutic protocols are 
fundamental to prevent progression of coagulopathy and 
refractory shock.
References
1. Sauaia A, Moore FA, Moore EE et al. – Epidemiology of trauma 
deaths: a reassessment. J Trauma,1995;38:185-193.
2. Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, 
Cotton BA – Early prediction of massive transfusion in trauma: 
simple as ABC (assessment of blood consumption)? J Trauma, 
2009;66:346-352.
3. Malone DL, Hess JR, Fingerhut A – Massive transfusion practices 
around the globe and a suggestion for a common massive 
transfusion protocol. J Trauma,2006;60:S91-96.
4. Miller RD, Robbins TO, Tong MJ, Barton SL – Coagulation 
defects associated with massive blood transfusions. Ann 
Surg,1971;174:794-801.
5. Beekley AC – Damage control resuscitation: a sensible approach 
to the exsanguinating surgical patient. Crit Care Med, 
2008;36:S267-274.
6. Sperry JL, Ochoa JB, Gunn SR et al. – An FFP:PRBC transfusion 
ratio >/=1:1.5 is associated with a lower risk of mortality after 
massive transfusion. J Trauma, 2008;65:986-993.
7. Dente CJ, Shaz BH, Nicholas JM et al. – Early predictors of 
massive transfusion in patients sustaining torso gunshot wounds 
in a civilian level I trauma center. J Trauma, 2010;68:298-
304.
8. Krausz MM. Fluid resuscitation strategies in the Israeli army. J 
Trauma, 2003;54:S39-42.
9. Bickell WH, Wall MJ, Jr., Pepe PE et al. – Immediate versus 
delayed fluid resuscitation for hypotensive patients with 
penetrating torso injuries. N Engl J Med,1994;331:1105-1109.
10. Parr MJ, Alabdi T – Damage control surgery and intensive care. 
Injury, 2004;35:713-722.
11. Blackbourne LH – Combat damage control surgery. Crit Care 
Med, 2008;36:S304-310.
12. Bormanis J – Development of a massive transfusion protocol. 
Transfus Apher Sci, 2008;38:57-63.
13. Hardy JF, De Moerloose P, Samama M – Massive transfusion and 
coagulopathy: pathophysiology and implications for clinical 
management. Can J Anaesth, 2004;51:293-310.
14. Brohi K, Cohen MJ, Davenport RA – Acute coagulopathy of 
trauma: mechanism, identiﬁ cation and effect. Curr Opin Crit 
Care, 2007;13:680-685.
15. Scalea TM, Bochicchio KM, Lumpkins K et al. – Early aggressive 
use of fresh frozen plasma does not improve outcome in critically 
injured trauma patients. Ann Surg, 2008;248:578-584.
16. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie 
RC, Pittet JF – Acute traumatic coagulopathy: initiated by 
hypoperfusion: modulated through the protein C pathway? Ann 
Surg, 2007;245:812-818.
17. Spahn DR, Rossaint R – Coagulopathy and blood component 
transfusion in trauma. Br J Anaesth, 2005;95:130-139.
18. Cosgriff N, Moore EE, Sauaia A, Kenny-Moynihan M, Burch JM, 
Galloway B – Predicting life-threatening coagulopathy in the 
massively transfused trauma patient: hypothermia and acidoses 
revisited. J Trauma, 1997;42:857-861.
19. Lier H, Krep H, Schroeder S, Stuber F – Preconditions of 
hemostasis in trauma: a review. The inﬂ uence of acidosis, 
hypocalcemia, anemia, and hypothermia on functional 
hemostasis in trauma. J Trauma, 2008;65:951-960.
20. Martini WZ, Pusateri AE, Uscilowicz JM, Delgado AV, Holcomb 
JB – Independent contributions of hypothermia and acidosis to 
coagulopathy in swine. J Trauma, 2005;58:1002-1009.
21. Engstrom M, Schott U, Romner B, Reinstrup P. Acidosis impairs 
the coagulation: A thromboelastographic study. J Trauma, 
2006;61:624-628.
